Monday, 01 June 2020
India Pharmaceutical News
India Pharmaceutical News
Read Top India Pharmaceutical News Headlines and Daily Updates in English
Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-19 patients
Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covi...
Lupin's Q4 net profit rises 35 pc to Rs 390 crore
Pharma major Lupin Ltd has reported 34.5 per cent rise in its consolidated net profit to Rs 389.6 crore for the January to March quarter (Q4 FY20) as compared to Rs 289.5 crore in...
GSK to produce 1bn doses of Covid-19 vaccine booster next year
Pharmaceutical giant GlaxoSmithKline on Thursday said it plans to produce 1 billion doses of coronavirus vaccine adjuvant, an ingredient that makes vaccines work better, in 2021 t...
Pharmacy and Biotechnology students of Chandigarh University gets placed in top pharmaceutical multinationals
With India ranking third globally in the production of medicines and largest producer of generic medicines, the pharmaceutical sector of the country has grown in leaps and bounds ...
Glenmark to start new phase 3 clinical trial for hospitalised patients of moderate COVID-19
Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COV...
Glenmark to start trial combining 2 anti-viral drugs on India Covid patients
Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospi...
Indian Immunologicals working on Covid-19 vaccine
Leading vaccine maker Indian Immunologicals Limited (IIL) is developing a vaccine for coronavirus in a cross-continental collaboration. ...
Serum Institute CEO says vaccine development is like rollercoaster
Adar Poonawalla, CEO, Serum Institute of India (SII), said on Thursday that developing a vaccine is like a rollercoaster ride with ups and downs....
AstraZeneca receives USD 1bn US investment for Oxford vaccine
Drugmaker AstraZeneca on Thursday said it received support of more than USD 1 billion from the US Health Departments's Biomedical Advanced Research and Development Authority (BARD...
Strides Pharma to conduct trials for potential Covid-19 drug
Strides Pharma Science said on Thursday that it has received approval to conduct clinical trials of antiviral drug Favipiravir, a potential drug for Covid19 cure. ...
Bharat Biotech, Thomas Jefferson varsity to work on Covid vaccine
Leading vaccine maker Bharat Biotech on Wednesday announced that it has signed an exclusive deal with Thomas Jefferson University of Philadelphia to develop a new vaccine candidat...
Natco donates Chloroquine for international study to prevent SARS-CoV-2 infection
Natco Pharma Ltd said on Tuesday it has donated Chloroquine phosphate tablets through its marketing partner in the United States Rising Pharmaceuticals to support a global clinica...
Everlywell's at-home COVID-19 nasal swab test kit gets FDA nod
Health and wellness company Everlywell's at-home COVID-19 testing kit that allows people to self-collect a nasal sample at home and send it to specified laboratories for diagnosti...
ELISA kits produced by Zydus Cadila has 98pc sensitivity: ICMR
Four days after successfully developing the first indigenous anti-SARS-CoV-2A (Covid-19) human IgG ELISA test kit for antibody detection of the deadly virus, the ICMR on Thursday ...
COVID-19: Cipla enters into licensing pact with Gilead to manufacture and distribute Remdesivir
Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine...
SRL Diagnostics joins hand with Housejoy to launch mobile health clinic vans in Bengaluru
SRL Diagnostics, one of India's leading diagnostics chain has joined hands with Housejoy, a home maintenance company to develop mobile testing vans which will be deployed across B...
Gilead inks pact with 3 Indian drugmakers to produce, sell Remdesivir
US drug-maker Gilead Sciences has signed non-exclusive voluntary licensing agreements with three Indian pharmaceutical companies -- Mumbai-headquartered Cipla, Hyderabad-based Het...
Cipla 2nd Indian firm to manufacture, sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing agreement with US-based Gilead Sciences for the manufacturing and distribution ...
Noida-based Jubilant inks packs with Gilead to produce, sell remdesivir
Noida-based Jubilant Life Sciences on Tuesday announced that its subsidiary Jubilant Generics Ltd has entered into a non-exclusive licensing agreement with US-based Gilead Science...
Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for COVID-19 patients in India
Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so....
Corona aftershocks: Ricky Martin to provide mental health support
Sara Ali Khan shares her weight loss journey
Vidya Balan: Always great to watch older films
Vinesh Phogat to be recommended for Khel Ratna by WFI
Summer Alert! Celebs brace the heat by stripping down to their bikinis
Marketing -- In the times of the rogue virus
Music may be evergreen, composers are not
Elli AvrRam turns into 'beetroot ki dukaan'
Kareena Kapoor continues her 'kaftan series'
Terms of Service